Transversal fields of action

Transversal fields of action

Methodological approach of EuroBloodNet has been shaped in accordance with ongoing EU activities to contribute to innovative, efficient and sustainable health systems and facilitate access to better and safer healthcare for EU citizens. Our efforts to improve the delivery of cross-border care to RHD patients will be undertaken in accordance with the Directive on Cross-Border Healthcare (2011/24/EU).

Five main Transversal Fields of action (TFA) has been established to implement annual work plan aiming to achieve EuroBloodNet goals. Each TFA is led by one oncological hub coordinador, one non-oncological hub coordinator and one European Patients Advocacy Group (ePAG) representative coordinator:

TFA 1 Cross border health

TFA on cross-border health aims to establish a referral system for patients and samples in order to ensure the same level of access to healthcare across Europe.

TFA 2 Best practices

TFA on best practices aims to compile, create, and assess their implementation, alongside disseminating guidelines in RHD

TFA 3 Continuing medical education

TFA on CME aims to spread cutting-edge knowledge and facilitate continuous medical education in the field of RHD.

TFA 4 Telemedicine

TFA on Tele-medicine aims to facilitate inter-professional consultation by sharing of expertise and safety exchange of clinical information.

TFA 5 Clinical trials and research.

TFA on Clinical Trials and Research aims to foster European cooperation for epidemiological surveillance, development of high specialized procedures for diagnosis, innovative treatments and research.

Transversal Fields of Action Coordinators

Cross border health
Oncological Jane Apperley Imperial College Healthcare NHS Trust (ICHNT)
Non oncological Raffaella Colombatti Azienda Ospedaliera Università di Padova
ePAG Ananda Plate Myeloma Patients Europe
Best practices
Oncological Luca Malcovati Fondazione IRCCS Policlinico San Matteo (Pavia)
Non oncological Achille Iolascon Azienda Ospedaliera Universitaria Federico II
ePAG Amanda Bok European Haemophilia Consortium (EHC)
Continuing medical education
Oncological Dominique Bron Institut Jules Bordet
Non oncological Patricia Aguilar-Martinez Montpellier University Hospital (CHU de Montpellier)
ePAG Jan Geissler Leukemia Patient Advocates Foundation
Tele-medicine
Oncological Andreas Engert University Hospital Cologne
Non oncological Béatrice Gulbis Cliniques Universitaires de Bruxelles - Hopital Erasme
ePAG Sophie Wintrich MDS UK Patient Support Group (and MDS Alliance)
Clinical Trials and Research
Oncological Matteo della Porta IRCCS Humanitas Research Hospital (Milan)
Non oncological Antonio Piga San Luigi Gonzaga University Hospital
ePAG Angelo Loris Brunetta Associazione Ligure Thalassemici Onlus